3 unknown, 2 completed, 1 active not recruiting, 1 recruiting. 3 Phase 4, 2 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 2 | Completed 1, Suspended 1 |
Follow GV-971: new trials by email Literature Review of GV-971 trials Research Report on GV-971
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease GV-971, Placebo - Alzheimer's Disease | Phase 4 | Recruiting | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 1312 | 2023-08-31 | 2023-11-09 |
| Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease Memantine Oral Tablet, GV-971 capsule - Treatment, Efficacy | Phase 4 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 150 | 2022-07-01 | 2022-07-07 |
| Long-term Efficacy and Safety Study of GV-971 Sodium Oligomannate Capsules (GV-971) - Alzheimer Disease | Phase 4 | Active not recruiting | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 800 | 2021-12-07 | 2024-11-15 |
| Efficacy and Safety of Donepezil and Sodium Oligomannate in Patients With Mild to Moderate Alzheimer's Disease Donepezil, GV-971 - Alzheimer Disease | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 150 | 2021-12-01 | 2021-11-10 | |
| A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease GV-971, Placebo - Alzheimer Disease | Phase 3 | Suspended | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | 2046 | 2020-10-27 | 2022-11-23 |
| A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects GV-971, Placebo - Pharmacokinetics, Safety | Phase 1 | Unknown | Shanghai Greenvalley Pharmaceutical Co., Ltd. | 45 | 2018-10-15 | 2018-10-22 |
| A Study to Assess the Bioavailability of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Male Subjects GV-971, Placebos - Bioavailability | Phase 1 | Completed | Shanghai Greenvalley Pharmaceutical Co., Ltd. | 15 | 2016-11-01 | 2018-02-07 |
| An Efficacy and Safety Study of Sodium Oligo-mannurarate (GV-971) Capsule for the Treatment of Alzheimer's Disease Sodium oligo-mannurarate 900mg, Placebo - Mild to Moderate Alzheimer Disease, Cognitive Impairment | Phase 3 | Completed | Shanghai Greenvalley Pharmaceutical Co., Ltd. | 818 | 2014-04-01 | 2018-10-10 |
Alzheimer Disease (5) · Cognitive Dysfunction (1)
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. (3) · Shanghai Greenvalley Pharmaceutical Co., Ltd. (3) · First Affiliated Hospital Xi'an Jiaotong University (2)
China (6) · Australia (1) · Canada (1) · Czechia (1) · France (1) · Hong Kong (1) · Netherlands (1) · Poland (1) · Taiwan (1) · United States (1)
Chen Yu, MD (1)